RUSSO, EDDA
 Distribuzione geografica
Continente #
NA - Nord America 3.857
EU - Europa 3.510
AS - Asia 2.778
SA - Sud America 269
AF - Africa 49
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.509
Nazione #
US - Stati Uniti d'America 3.805
RU - Federazione Russa 1.328
CN - Cina 829
SG - Singapore 829
PL - Polonia 747
IT - Italia 584
HK - Hong Kong 388
KR - Corea 297
IE - Irlanda 229
BR - Brasile 204
SE - Svezia 169
DE - Germania 112
VN - Vietnam 96
IN - India 89
FI - Finlandia 81
ID - Indonesia 64
JO - Giordania 62
FR - Francia 57
NL - Olanda 57
AU - Australia 45
GB - Regno Unito 44
ES - Italia 28
CA - Canada 27
AR - Argentina 24
CH - Svizzera 21
JP - Giappone 20
CZ - Repubblica Ceca 13
MX - Messico 13
BD - Bangladesh 12
EC - Ecuador 12
UA - Ucraina 12
UZ - Uzbekistan 12
IQ - Iraq 11
TR - Turchia 11
CI - Costa d'Avorio 10
CO - Colombia 10
ZA - Sudafrica 10
IL - Israele 8
PK - Pakistan 8
CL - Cile 7
DO - Repubblica Dominicana 6
EG - Egitto 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
KG - Kirghizistan 5
RO - Romania 5
SA - Arabia Saudita 5
UG - Uganda 5
AT - Austria 4
MY - Malesia 4
PY - Paraguay 4
TH - Thailandia 4
VE - Venezuela 4
BJ - Benin 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
PH - Filippine 3
TN - Tunisia 3
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
LB - Libano 2
OM - Oman 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
EU - Europa 1
GI - Gibilterra 1
GT - Guatemala 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
UY - Uruguay 1
YT - Mayotte 1
Totale 10.509
Città #
Santa Clara 1.215
Warsaw 745
Singapore 598
Ashburn 474
Hong Kong 325
Hefei 303
Seoul 283
Dublin 224
Chandler 217
Fairfield 171
Beijing 139
Florence 133
New York 99
Seattle 97
Woodbridge 80
Houston 79
Los Angeles 69
Wilmington 69
Buffalo 66
Munich 64
Cambridge 55
Jakarta 52
Lawrence 51
Altamura 48
Moscow 48
Kent 46
Dallas 40
Melbourne 40
Princeton 39
Mumbai 38
Boston 33
Ann Arbor 32
Fiesole 30
Shanghai 30
Lappeenranta 29
Paris 29
Chicago 27
Pune 26
Dong Ket 25
Helsinki 23
Ho Chi Minh City 23
Rome 23
San Diego 18
Boardman 17
Milan 17
Phoenix 17
Turku 17
London 16
Medford 16
São Paulo 16
Tokyo 16
West Jordan 16
Hanoi 15
Bern 13
Bengaluru 12
Clifton 12
Frankfurt am Main 12
Hillsboro 11
Abidjan 10
San Francisco 10
Tashkent 10
Tianjin 10
Toronto 10
Berlin 9
Falls Church 9
Prague 9
Salt Lake City 9
Yubileyny 9
Amsterdam 8
Bologna 8
Amman 7
Atlanta 6
Baghdad 6
Catania 6
Guangzhou 6
Montreal 6
Norwalk 6
Redondo Beach 6
Shenzhen 6
Andover 5
Bari 5
Belo Horizonte 5
Brooklyn 5
Castelliri 5
Curitiba 5
Falkenstein 5
Fortaleza 5
Gwangju 5
Izmir 5
Jacksonville 5
Johannesburg 5
Kampala 5
Redwood City 5
St Petersburg 5
Sydney 5
The Dalles 5
Washington 5
Bagno a Ripoli 4
Barcelona 4
Brno 4
Totale 6.746
Nome #
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 351
Crohn's Colitis: Development of a multiplex gene expression assay comparing mRNA levels of susceptibility genes 336
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 249
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 237
Evaluation and comparison of short chain fatty acids composition in gut diseases 216
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 214
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 211
Multiplex gene expression profile in inflamed mucosa of patients with Crohn’s disease ileal localization: A pilot study 211
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 206
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 195
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease 194
null 181
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature 179
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 177
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance 176
Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test 174
Circulating Calprotectin (cCLP) in autoimmune diseases 166
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 166
Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? 162
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 160
Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic 156
The interplay between the microbiome and the adaptive immune response in cancer development 155
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 154
Exploring the food-gut axis in immunotherapy response of cancer patients 154
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 153
Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine 152
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 151
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 146
JAK inhibitors and autoimmune rheumatic diseases. 146
Surgery for Sporadic Primary Hyperparathyroidism: Evolution over the Last Twenty Years in a Monocentric Setting 144
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 143
Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study 142
Facial Skin Microbiome: Aging-Related Changes and Exploratory Functional Associations with Host Genetic Factors, a Pilot Study 140
Structural, evolutionary and genetic analysis of the histidine biosynthetic "core" in the genus Burkholderia 140
Role of diet and gut microbiota on Colorectal cancer immunomodulation 140
Is the age at surgery in Crohn's disease clinically relevant? Differences and peculiarities: a wide single centre experience after long-term follow-up 138
Effects of the learning curve on operative time and lymph node harvesting during robotic gastrectomy 138
The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers 138
Crohn's disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors 134
Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases 133
Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease 132
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 131
Inadequate food literacy is related to the worst health status and limitations in daily life in subjects with inflammatory bowel disease 126
A two-stage strategy for early and accurate detection of B. cepacia in routine clinical analysis involving CF patients. Identification of Burkholderia cepacia strains by LAMP and SNuPE 126
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 126
LYSOZYME INTERACTION WITH NEGATIVELY CHARGED LIPID BILAYERS: PROTEIN AGGREGATION AND MEMBRANE FUSION 126
MICROBIOTA-INFLAMMATION-BRAIN AXIS IN HEART FAILURE: NEW FOOD, BIOMARKERS AND AI APPROACH FOR THE PREVENTION OF UNDERNUTRITION IN OLDER-AMBROSIA 126
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 125
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 122
Long-Term Follow-Up, Association between CARD15/NOD2 Polymorphisms, and Clinical Disease Behavior in Crohn's Disease Surgical Patients 121
Thyroidectomy for cancer: The surgeon and the parathyroid glands sparing 118
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 118
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 115
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 111
Involvement of MIR-126 and MMP9 in the Pathogenesis of Intra-Abdominal Fistulizing Crohn’s Disease: A Brief Research Report 108
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 107
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 105
Editorial: The mechanism of immune cells in the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC) 104
Identification of Burkholderia cepacia complex species by LAMP or SNuPE analysis of his genes 103
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease 102
Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an ai approach 99
Transthyretin aggregates affect viability and electrical properties of cardiomyocytes 93
Structural, functional and evolutionary analysis of histidine biosynthetic genes in Burkholderia strains 91
Musculin does not modulate the disease course of Experimental Autoimmune Encephalomyelitis and DSS colitis 90
Structural, evolutionary and genetic analysis of the histidine biosynthetic "core" in the genus Burkholderia 89
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 89
The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective 87
Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1 85
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma 83
Fecal microbiome in systemic sclerosis, in search for the best candidate for microbiota-targeted therapy for small intestinal bacterial overgrowth control 80
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 79
Microbiota and viral hepatitis: State of the art of a complex matter 76
On the origin and evolution of operons: the piece-wise assembly of histidine biosynthetic genes in proteobacteria 69
Identification of Burkholderia cepacia complex species by Loop Mediated Isothermal Amplification (LAMP) or Single Nucleotide Primer Extension (SNuPE) analysis of his genes 64
Interactions of lysozyme with phospholipid vesicles: effects of vesicle biophysical features on protein misfolding and aggregation 55
Totale 10.639
Categoria #
all - tutte 33.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021329 0 0 0 0 0 50 32 39 53 92 26 37
2021/2022283 10 10 16 17 7 18 10 31 20 10 53 81
2022/20231.116 69 175 30 72 80 174 141 67 122 42 79 65
2023/2024819 27 46 89 44 62 164 35 166 12 56 64 54
2024/20254.017 126 382 236 626 1.070 559 125 166 208 101 175 243
2025/20262.857 607 704 606 334 591 15 0 0 0 0 0 0
Totale 10.639